产品标题 产品货号 产品规格 厂家
Sialic acid binding Ig-like lectin 10 (SIGLEC10), transcript variant 2 from ORIGENE TECHNOLOGIESLY433382100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 10 (SIGLEC10), transcript variant 3 from ORIGENE TECHNOLOGIESLY433331100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 11 (SIGLEC11), transcript variant 1 from ORIGENE TECHNOLOGIESLY403267100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 11 (SIGLEC11), transcript variant 1 from ORIGENE TECHNOLOGIESLY432355100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 11 (SIGLEC11), transcript variant 2 from ORIGENE TECHNOLOGIESLY427568100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 12 (SIGLEC12), transcript variant 1 from ORIGENE TECHNOLOGIESLY409355100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 12 (SIGLEC12), transcript variant 2 from ORIGENE TECHNOLOGIESLY409587100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 6 (SIGLEC6), transcript variant 1 from ORIGENE TECHNOLOGIESLY429056100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 6 (SIGLEC6), transcript variant 1 from ORIGENE TECHNOLOGIESLY420052100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 6 (SIGLEC6), transcript variant 3 from ORIGENE TECHNOLOGIESLY404755100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 6 (SIGLEC6), transcript variant 4 from ORIGENE TECHNOLOGIESLY433004100 ugORIGENE TECHNOLOGIES
Sialic acid binding Ig-like lectin 6 (SIGLEC6), transcript variant 5 from ORIGENE TECHNOLOGIESLY432981100 ugORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, granulosa cell from ORIGENE TECHNOLOGIESCS8041965x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, granulosa cell from ORIGENE TECHNOLOGIESCS6151465x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, granulosa cell from ORIGENE TECHNOLOGIESCS6151475x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, granulosa cell from ORIGENE TECHNOLOGIESCS6151485x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, granulosa cell from ORIGENE TECHNOLOGIESCS6151495x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, granulosa cell from ORIGENE TECHNOLOGIESCS6151505x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mixed germ cell from ORIGENE TECHNOLOGIESCS8029535x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mixed germ cell from ORIGENE TECHNOLOGIESCS8029545x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mixed germ cell from ORIGENE TECHNOLOGIESCS8029555x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mixed germ cell from ORIGENE TECHNOLOGIESCS6101975x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mixed germ cell from ORIGENE TECHNOLOGIESCS6101985x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7002205x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7002215x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7002225x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7038945x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7038955x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7038965x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7041675x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7041685x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7098985x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7111485x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7111495x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7111505x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7117575x5umORIGENE TECHNOLOGIES
Human Ovary: left; Tumor of ovary, mucinous, borderline from ORIGENE TECHNOLOGIESCS7117595x5umORIGENE TECHNOLOGIES
Gtpbp8 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5074431 kitORIGENE TECHNOLOGIES
GTPBP1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31510310 ugORIGENE TECHNOLOGIES
GTPBP10 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31045110 ugORIGENE TECHNOLOGIES
GTPBP3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30083610 ugORIGENE TECHNOLOGIES
GTPBP5 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30566310 ugORIGENE TECHNOLOGIES
GTPBP6 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30021710 ugORIGENE TECHNOLOGIES
GTPBP8 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30565610 ugORIGENE TECHNOLOGIES
GTP cyclohydrolase 1 (GCH1), transcript variant 1 from ORIGENE TECHNOLOGIESLY400058100 ugORIGENE TECHNOLOGIES
GTP cyclohydrolase 1 (GCH1), transcript variant 2 from ORIGENE TECHNOLOGIESLY422611100 ugORIGENE TECHNOLOGIES
GTP cyclohydrolase I feedback regulator (GCHFR) from ORIGENE TECHNOLOGIESLY417419100 ugORIGENE TECHNOLOGIES
GTSE1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4028291 kitORIGENE TECHNOLOGIES
Gtse1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5074441 kitORIGENE TECHNOLOGIES
GTSF1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4060991 kitORIGENE TECHNOLOGIES
 |< < 2161 2162 2163 2164 2165 2166 2167 2168 2169 > >| 第 2165/6274 页